DailyDoctor Archive Specialties Get app
All anaesthesiology briefings

The edition · Anaesthesiology

1 in 71 patients on GLP-1 agonists regurgitated or aspirated under anaesthesia, against 1 in 802 not taking them — mostly at emergence

A UK national cohort of 47,039 anaesthetics puts a number on GLP-1 aspiration risk; drug allergy labels were associated with more complications; a caudal-versus-penile block trial and a dexamethasone-versus-ondansetron trial after caesarean; and a Class II dexmedetomidine recall.

The edition in brief

Today's anaesthesia edition closes on a national prospective UK cohort (Anaesthesia, 16 September) of 47,039 adults at 119 sites. One in 36 was taking a GLP-1 receptor agonist. Pulmonary aspiration or regurgitation occurred in 1.41% of them against 0.12% of others (OR 11.39, 6.47 to 20.05), most often at emergence, despite varied precautions. It is observational and unadjusted in the abstract, but the size of the difference warrants a plan for every patient taking one. The lead is a BJA cohort (10 September) of 13,646 surgical patients: the 29% carrying a drug allergy label had more 30-day complications (25% vs 20%; OR 1.21) and more infections. A multicentre randomised trial in children under 2 having hypospadias repair (RAPM, 11 September), stopped early, found no clear difference in fistula between caudal and penile block (RR 0.98, 0.35 to 2.76), with less opioid after caudal. A 95-patient trial after caesarean (Anesthesia & Analgesia, 10 September) found dexamethasone 8 mg no better than ondansetron 4 mg as first-line antiemetic. On regulation, the FDA has a Class II recall of Baxter's premixed dexmedetomidine 4 mcg/mL in 100 mL Galaxy containers for manufacturing-practice deviations. The pearl is on asking the GLP-1 question at pre-assessment.

In this edition
01
Clinical update

Drug allergy labels were associated with more complications after surgery

Question every drug allergy label at pre-assessment — labelled patients had more complications and infections, and most labels are wrong.

1 min · British journal of anaesthesiaRead →
Primary outcome
30-day postoperative complications (composite)
Effect
25% vs 20%; OR 1.21 (95% CI 1.10 to 1.34)
02Research

Hypospadias repair under 2: no clear fistula difference between caudal and penile block, and caudal needed less opioid

Caudal block need not be avoided for hypospadias repair on fistula grounds; it gave better analgesia in this trial.

1 min · Regional anesthesia and pain medicineRead →
03Research

After caesarean, dexamethasone was no better than ondansetron as first-line antiemetic

For antiemetic prophylaxis after caesarean, choose dexamethasone or ondansetron on local practice; neither was better in this trial.

1 min · Anesthesia and analgesiaRead →
04Regulatory

FDA Class II recall: Baxter premixed dexmedetomidine 4 mcg/mL in 100 mL Galaxy containers

Check with pharmacy whether you stock the recalled Baxter premixed dexmedetomidine bags, and switch lots if so.

1 minRead →
05Pearl

Ask 'Any weekly injections?' at pre-assessment

At pre-assessment, ask by name about weekly GLP-1 injections, including those bought privately for weight loss.

1 minRead →
06
Practice changer

GLP-1 agonists: aspiration or regurgitation in 1 in 71 anaesthetics

Plan airway management for every patient taking a GLP-1 agonist, and treat emergence as a high-risk moment as well as induction.

1 min · AnaesthesiaRead →
Primary outcome
Proportion receiving GLP-1 RAs; aspiration or regurgitation (secondary)
Effect
1.41% vs 0.12%; OR 11.39 (95% CI 6.47 to 20.05)

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for anaesthesiology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free